Achieve Life Sciences (ACHV) Asset Utilization Ratio (2012 - 2013)
Achieve Life Sciences (ACHV) recorded quarterly Asset Utilization Ratio of 0.38 in Q2 2013, up 26.54% on a QoQ basis from 0.3 in Q1 2013, and up 603.28% year-over-year from 0.05 in Q2 2012.
Achieve Life Sciences (ACHV) Asset Utilization Ratio (2012 - 2013) Analysis & Trends
Achieve Life Sciences has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.38 for Q2 2013.
- Quarterly Asset Utilization Ratio rose 603.28% year-over-year to 0.38 in Q2 2013, while the trailing twelve-month figure through Jun 2013 was 0.38 (up 603.28% YoY) and the FY2012 annual result came in at 0.27, up 284.7% from the prior year.
- Asset Utilization Ratio improved to 0.38 in Q2 2013, from 0.3 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.38 in Q2 2013 and troughed at 0.05 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 0.55 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 0.38 |
| Mar 31, 2013 | 0.30 |
| Dec 31, 2012 | 0.22 |
| Sep 30, 2012 | 0.11 |
| Jun 30, 2012 | 0.05 |
| Mar 31, 2012 | 0.06 |